Alpine 4 Holdings Inc (OTCQB:ALPP) announced that its subsidiary Alternative Laboratories LLC has secured a new $2 million order to kick off the third quarter.
The order is related to the production of a high-quality, nutrient-rich gut health product line for a health food company.
Alt Labs, a private label contract manufacturer in Florida, specializes in the manufacturing and packaging of liquids, powders, tablets, capsules and other nutritionals. Its product formulation ability access to and global raw materials provides its clients with unique "first to market" products and cutting-edge innovations, the company said.
READ: Alpine 4 says its two aerospace subsidiaries are combining to form Vayu Aerospace Corporation
"With the global nutraceutical market size projected to reach $722.49 billion by 2027, Alt Labs is positioning itself to be a leader in contract manufacturing of nutraceuticals both in the United States and abroad,” Alpine 4 CEO Kent Wilson said in a statement. “We are investing heavily in new equipment, training and software to meet our customers’ growing global demand for health supplements."
The deal is an impressive way to begin the year’s second half, Alt Labs COO Mark Wesolaski noted.
"We're very excited to start Q3 with an order of this magnitude,” Wesolaski said. “We plan to leverage improved efficiencies across our blending, filling and supply chain functions to deliver these 6 products to our customer in the next 8 weeks. The delivery of these products to our customer will facilitate their rapid growth, setting the stage for a very strong finish to 2021 that will lead into what we believe to be a record year for 2022."
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel